Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind placebo-controlled study of KDTV001 injection for cervical HSIL
CTR20263561Phase 2Active
- Sponsor
- KDGene
- Start
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of KDTV001 in cervical intraepithelial neoplasia (CIN), human papillomavirus infection, sponsored by KDGene. Started Sep 2026; status: active.
02
Drugs
KDTV001
03
Conditions
cervical intraepithelial neoplasia (CIN)human papillomavirus infection
Beyond the preview
Go deeper on CTR20263561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263561.